Spathopoulou, Angeliki http://orcid.org/0000-0001-9239-6222
Podlesnic, Martina
De Gaetano, Laura
Kirsch, Elena Marie http://orcid.org/0000-0001-5617-3873
Tisch, Marcel http://orcid.org/0000-0002-3907-6657
Finotello, Francesca http://orcid.org/0000-0003-0712-4658
Aigner, Ludwig http://orcid.org/0000-0002-1653-8046
Günther, Katharina http://orcid.org/0000-0002-2954-4883
Edenhofer, Frank http://orcid.org/0000-0002-6489-714X
Funding for this research was provided by:
fwf (F7804-B)
University of Innsbruck and Medical University of Innsbruck
Article History
Accepted: 14 February 2024
First Online: 22 March 2024
Declarations
:
: The human fibroblast (hF) that were used for cellular reprogramming were obtained from commercially available sources (ATCC). Reprogramming experiments were performed under ethical approval of the ethics committee of the Medical University of Innsbruck (Reprogramming fibroblasts into neurons to analyze cellular aspects of mild cognitive impairment and Alzheimer's Disease; Approval number EK Nr: 1053/2018; April 19, 2019).
: Not applicable.
: All the authors approved the final version of the manuscript and consent for its publication.
: The authors declare that they have no competing interests.